Medicine & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Andrx Corp.
Andrx reports profits of $32.2 million, provides update on merger
June 2nd, 2006
Andrx Corp. (ADRX) announced its financial results for the 3 months ended March 31, 2006, which are discussed more extensively in Andrx's Form 10-Q for the 2006 quarter being filed with the U.S. Securities and Exchange Commission (SEC). On March 12, 2006, Andrx entered into an agreement and plan of merger with Watson whereby each share of its common stock outstanding immediately prior to the merger will be converted into $25.00 in cash. Consummation of the merger is subject to the satisfaction of certain customary closing conditions including, among others, (i) approval of the merger by Andrx's stockholders, (ii) the expiration of the applicable waiting period under the...
Source: Medicine & Law Weekly (2006-06-02)
|
